Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20120253288 A1
Publication typeApplication
Application numberUS 13/389,867
PCT numberPCT/EP2010/062433
Publication date4 Oct 2012
Filing date26 Aug 2010
Priority date27 Aug 2009
Also published asCA2771373A1, CA2771668A1, CN102481231A, CN102596149A, EP2470149A2, EP2470149B1, EP2470150A2, US8821452, US20130226095, WO2011023736A2, WO2011023736A3, WO2011023737A2, WO2011023737A3
Publication number13389867, 389867, PCT/2010/62433, PCT/EP/10/062433, PCT/EP/10/62433, PCT/EP/2010/062433, PCT/EP/2010/62433, PCT/EP10/062433, PCT/EP10/62433, PCT/EP10062433, PCT/EP1062433, PCT/EP2010/062433, PCT/EP2010/62433, PCT/EP2010062433, PCT/EP201062433, US 2012/0253288 A1, US 2012/253288 A1, US 20120253288 A1, US 20120253288A1, US 2012253288 A1, US 2012253288A1, US-A1-20120253288, US-A1-2012253288, US2012/0253288A1, US2012/253288A1, US20120253288 A1, US20120253288A1, US2012253288 A1, US2012253288A1
InventorsUwe Dasbach, Irina Lanin, Peggy Rabe
Original AssigneeSanofi-Aventis Deutschland Gmbh
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Reminder device for drug delivery devices
US 20120253288 A1
Abstract
The present invention relates to a reminder device for a drug delivery device, comprising: a base member, an adjusting element movably disposed with respect to the base member between at least two stop positions, and a display means comprising an information surface being only partially discernible through an aperture, wherein at least two designated segments of the information surface become selectively discernible by a displacement of the adjusting element relative to the base member.
Images(2)
Previous page
Next page
Claims(15)
1. A reminder device for a drug delivery device, comprising:
a base member,
an adjusting element movably disposed with respect to the base member between at least two stop positions, and
a display means comprising an information surface being only partially discernible through an aperture, wherein at least two designated segments of the information surface become selectively discernible by a displacement of the adjusting element relative to the base member.
2. The reminder device according to claim 1, wherein the base member is an integral housing component of the drug delivery device.
3. The reminder device according to claim 1, wherein the aperture is formed in the base member.
4. The reminder device according to claim 1, wherein the information surface is disposed on the adjusting element.
5. The reminder device according to claim 1, wherein the adjusting element is slidably disposed in the base member in an axial direction between at least a distal and a proximal stop position.
6. The reminder device according to claim 1, wherein the adjusting element comprises a sliding element having a gripping member protruding through the aperture.
7. The reminder device according to claim 1, wherein the adjusting element and the base member comprise mutually corresponding latching elements for keeping the adjusting element in a selected position.
8. The reminder device according to claim 1, wherein the base member is of substantially cylindrical geometry.
9. The reminder device according to claim 1, wherein the adjusting element is rotatably mounted on the outer circumference of the base member.
10. The reminder device according to claim 1, wherein the aperture is formed in the adjusting element.
11. The reminder device according to claim 1, wherein the information surface is disposed on the circumference of the base member.
12. The reminder device according to claim 1, wherein the information surface comprises visible and/or haptic information.
13. A drug delivery device for dispensing a dose of a medicament by way of injection, comprising:
at least one housing component,
a cartridge filled with the medicament and being disposed in the housing and having a piston slidably disposed therein,
a drive mechanism comprising a piston rod to be operably engaged with the piston of the cartridge for dispensing of a dose of the medicament, and
a reminder device according to any one of the preceding claims.
14. The drug delivery device according to claim 13, wherein the housing component and the base member of the reminder device are integrally formed.
15. The drug delivery device according to claim 13, wherein the base member and/or the reminder device is detachably connectable with the housing component.
Description
    CROSS REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present application is a U.S. National Phase Application pursuant to 35 U.S.C. 371 of International Application No. PCT/EP2010/062433 filed Aug. 26, 2010, which claims priority to European Patent Application No. 09010974.5 filed on Aug. 27, 2009. The entire disclosure contents of these applications are herewith incorporated by reference into the present application.
  • FIELD OF THE INVENTION
  • [0002]
    The present invention relates to a reminder or indicator device particularly adapted for drug delivery devices for keeping a user of the device informed about a given time schedule to apply or to take a particular medicament.
  • BACKGROUND
  • [0003]
    With patients suffering chronic diseases, such like diabetes, frequent and regular administering of a particular medicament, like e.g. insulin has to be conducted. Since the patients are highly accustomed to a regular or irregular administering of the medicament, it may occur, that a patient already shortly after taking or injecting the medicament is no longer aware of this event. Hence, there is a certain danger, that the patient takes the medicament repeatedly.
  • [0004]
    In practical use, also another scenario may take place, wherein a patient simply forgets to take the medicament at a particular time of the day, e.g. in the morning.
  • [0005]
    Hence, with drug delivery devices particularly adapted and designed for self-medication, e.g. in a home environment, there always exists a non-negligible risk and danger of underdosage or overdosage, respectively.
  • [0006]
    Document U.S. Pat. No. 5,482,163 for instance discloses an indicator apparatus including a cylindrical support having a longitudinal axis, an outer surface and a tapered flange structure. There, an expandable indicator ring is disposed over the outer surface being axially displaceable along the longitudinal axis to engage the tapered flange structure and which causes expansion of an indicator ring. The expandable indicator ring is rotatable about the longitudinal axis over the outer surface to each of a plurality of selected positions.
  • [0007]
    However, such an indicator apparatus has not been considered to be applicable on pen-shape medical delivery devices for ergonomic as well as for technical reasons.
  • OBJECTS OF THE INVENTION
  • [0008]
    It is therefore an object of the present invention to provide a reminder device particularly adapted for a drug delivery device which is rather simple, both in construction as well as in regard of its handling.
  • [0009]
    The reminder device should be implemented in a space-saving and robust way. Moreover, the reminder device should be universally applicable and/or adaptable with various different types of drug delivery devices and medicaments to be administered therewith.
  • SUMMARY
  • [0010]
    The present invention provides a reminder device for a drug delivery device, such like a pen-type injector. The reminder device can be universally adapted and modified according to the shape and geometry of the drug delivery device. For instance, the reminder device can be integrated in the drug delivery device or can otherwise be provided as a separate device being interconnectable with the drug delivery device. The reminder or indicator device comprises a base member and an adjusting element which is moveably disposed with respect to the base member between at least two stop positions. Preferably, the adjusting element is moveably disposed in or on the base member, thereby serving as a guiding structure or guiding element along which the adjusting element can be moved. Hence, the base member may serve as a support or as a support structure allowing the adjusting element to be variably disposed between the two stop positions.
  • [0011]
    The reminder device further comprises a display means comprising an information surface. Display means and its information surface is arranged in such a way, that the information surface is only partially discernible through an aperture. Here, at least two designated segments or surface portions of the information surface become selectively discernible by a displacement of the adjusting element relative to the base member. For instance, when the adjusting element is in its first stop position, a first segment of the information surface is revealed while a second portion of the information surface remains concealed. With the adjusting element in its second stop position, the second surface portion of the information surface becomes discernible while the first surface portion is substantially concealed.
  • [0012]
    Consequently, the size of the aperture through which the information content is to be displayed typically matches with the size of the surface portion comprising a particular information, being typically related to a time schedule.
  • [0013]
    Therefore, the display means is particularly adapted to display time indicia or time information, like for instance morning, midday, evening, night. Further, depending on the type and characteristics of the medicament to be dispensed or to be injected by way of the drug delivery device, the display means preferably indicates a variety of time indicia that corresponds to the frequency, the particular medicament has to be administered.
  • [0014]
    The information surface may comprise symbols, words, particular abbreviations or numbers. Furthermore and depending on the type of information disposed on the information surface, the aperture may be designed as a through opening in the base member, e.g. allowing to haptically detect the information disposed underneath on the information surface. This way, the information provided on the information surface can be read by simply touching the information surface, which is generally considered beneficial for patients suffering impaired vision. In the case of visible information, such like printed information it is also conceivable to implement the aperture by way of a transparent surface portion in the base member.
  • [0015]
    According to a preferred embodiment, the base member is an integral housing component of the drug delivery device. Hence, the reminder device can be designed as an integral component of the drug delivery device.
  • [0016]
    Furthermore it is intended, that the patient after each application or usage of the drug delivery device manually moves the adjusting element to one of said at least two stop positions. This way, the reminder device can be indicative on whether a particular dose of the medicament has already been taken. By integrating the reminder device into the drug delivery device it can almost be guaranteed, that the configuration of the reminder device exactly matches with the temporal schedule according to which the medicament is to be administered.
  • [0017]
    According to another preferred aspect, the aperture is formed in the base member. With the adjusting element movably disposed inside the base member, at least one of the at least two designated segments of the information surface becomes discernible through the aperture. By having the aperture integrally formed in the base member or even in a housing component of the drug delivery device, construction and design of the reminder device can be kept on a rather simple and cost-efficient level.
  • [0018]
    According to another preferred embodiment, the information surface is disposed on the adjusting element. Correspondingly, the base member and its aperture are substantially fixed and by moving the adjusting element relative to the base member, a designated segment of the information surface can be displaced to the region defined by the aperture, this way revealing or concealing respective portions of the information surface of the adjusting element.
  • [0019]
    According to another preferred embodiment, the adjusting element is slidably disposed in or on the base member in an axial direction between at least a distal and a proximal stop position. In this context, the distal end of the drug delivery device faces towards the skin of the patient, whereas the proximal end of the drug delivery device faces away from an area of injection. The adjusting element can comprise a slider being slidably guided in or on the base member between at least its distal and its proximal stop position. Depending on whether the slider is in its proximal or distal stop position or in various designated positions therebetween, a respective and corresponding portion of the information surface is positioned in an overlapping manner with the aperture of the base member and can be thus displayed or sensed through touching.
  • [0020]
    In a further preferred embodiment, the adjusting element comprises a sliding element or a slider having a gripping member protruding through the aperture. In a longitudinal cross-sectional view, the slider or sliding element may comprise a T-structure and related to a substantially cylindrically shaped base member, the slider may feature an information surface substantially extending in axial direction, whereas the gripping member substantially extends radially outwardly. Preferably, the gripping member extends substantially perpendicular from the centre of the information surface, such that a distal and/or proximal margin of the aperture of the base member may eventually serve as an effective stopper for the gripping member.
  • [0021]
    Hence, since the gripping member radially outwardly or orthogonally protrudes from the display means and its information surface, axial displacement of the adjusting element in proximal and distal direction is limited by the gripping element hitting a respective proximal or distal margin of the aperture.
  • [0022]
    It is further of advantage, when the adjusting element and the base member comprise mutually corresponding latching elements for keeping the adjusting element in a selected position. By way of the latching elements disposed on the adjusting element as well as on or in the base member, inadvertent displacement of the adjusting element can be effectively prevented. For instance, the adjusting element may feature protruding pins at distal and/or proximal end sections of its display means. These pins may for instance project radially outwardly, hence towards an inside wall section of the base member. Correspondingly, the base member may feature respective radially inwardly protruding latching elements adapted to form a positive interlock or a snap-in feature with said radially outwardly protruding pins of the display means and/or of its adjusting element.
  • [0023]
    Axial position of mutually corresponding latching- or snap-in elements of the display means and the base member is chosen such, that the adjusting element is at least axially fixed in its at least two stop positions. Additionally, it is conceivable, that the display means comprises a toothed surface meshing with a flexible deformable ratchet member or the like.
  • [0024]
    In a further preferred embodiment and irrespective of the implementation of the base member as integral or separate part of the housing of the drug delivery device, the base member is of substantially cylindrical geometry. In such configuration, the adjusting element may, according to another preferred aspect, be rotatably mounted on the outer circumference of the base member. Hence, instead of slidably displacing the adjusting element, it is also conceivable to rotatably displace said adjusting element for selectively displaying designated segments of the information surface disposed underneath the adjusting element.
  • [0025]
    In this embodiment it is further of advantage, when the aperture is formed in the adjusting element while the information surface is disposed on the outer circumference of the base member. It may be also beneficial, when the information surface at least partially or entirely surrounds the circumference of the base member. Moreover, it is intended, that the adjusting element comprises a ring structure having an aperture and that by rotating the ring, a designated portion of the information surface becomes discernible through said aperture, either by way of visible perception or by way of tactile sensing.
  • [0026]
    Hence, the information surface may comprise visible and/or haptic information discernible either by way of visual perception or by way of touching.
  • [0027]
    In another independent aspect, the invention further relates to a drug delivery device for dispensing a dose of a medicament, preferably by way of injection. The drug delivery device comprises at least one housing component, e.g. a body component adapted to receive a drive mechanism and/or a cartridge holder component adapted to receive a cartridge filled with a medicament to be injected by the drug delivery device. Additionally, the drug delivery device comprises a cartridge filled with the medicament and having a piston slidably disposed therein. The piston typically acts as a proximal seal of the cartridge. By displacing the piston in distal direction, e.g. by way of a piston rod of a drive mechanism, a respective pressure builds up in the cartridge and if appropriately connected with a respective injection needle, a defined dose of the medicament can be expelled and thus dispensed.
  • [0028]
    The drug delivery device therefore has a drive mechanism that comprises the piston rod to be operably engaged with the piston of the cartridge for dispensing of a dose of the medicament.
  • [0029]
    The drug delivery device, which is typically designed as pen-type injector further comprises a reminder device as described above.
  • [0030]
    According to a further preferred aspect, the housing component of the drug delivery device and the base member of the reminder device are integrally formed. In other words, the base member can be fully integrated in the housing component. Hence, the housing component may serve as the base member of the reminder device. This way, implementation of the reminder device does not require separate and additional components. Only a housing component of the drug delivery device has to be modified accordingly in order to receive e.g. a respective display means slidably or rotatably mounted to the base member.
  • [0031]
    In a further, alternative embodiment, the base member and/or the reminder device is detachably connectable with the housing component of the drug delivery device. Here, the reminder device can be separately put on the market and already existing drug delivery devices can be retrofitted by a respective reminder device.
  • [0032]
    The term “medicament”, as used herein, means a pharmaceutical formulation containing at least one pharmaceutically active compound,
  • [0033]
    wherein in one embodiment the pharmaceutically active compound has a molecular weight up to 1500 Da and/or is a peptide, a proteine, a polysaccharide, a vaccine, a DNA, a RNA, a antibody, an enzyme, an antibody, a hormone or an oligonucleotide, or a mixture of the above-mentioned pharmaceutically active compound,
  • [0034]
    wherein in a further embodiment the pharmaceutically active compound is useful for the treatment and/or prophylaxis of diabetes mellitus or complications associated with diabetes mellitus such as diabetic retinopathy, thromboembolism disorders such as deep vein or pulmonary thromboembolism, acute coronary syndrome (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and/or rheumatoid arthritis,
  • [0035]
    wherein in a further embodiment the pharmaceutically active compound comprises at least one peptide for the treatment and/or prophylaxis of diabetes mellitus or complications associated with diabetes mellitus such as diabetic retinopathy,
  • [0036]
    wherein in a further embodiment the pharmaceutically active compound comprises at least one human insulin or a human insulin analogue or derivative, glucagon-like peptide (GLP-1) or an analogue or derivative thereof, or exedin-3 or exedin-4 or an analogue or derivative of exedin-3 or exedin-4.
  • [0037]
    Insulin analogues are for example Gly(A21), Arg(B31), Arg(B32) human insulin; Lys(B3), Glu(B29) human insulin; Lys(B28), Pro(B29) human insulin; Asp(B28) human insulin; human insulin, wherein proline in position B28 is replaced by Asp, Lys, Leu, Val or Ala and wherein in position B29 Lys may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
  • [0038]
    Insulin derivates are for example B29-N-myristoyl-des(B30) human insulin; B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N—(N-palmitoyl-Y-glutamyl)-des(B30) human insulin; B29-N—(N-lithocholyl-Y-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyhepta-decanoyl) human insulin.
  • [0039]
    Exendin-4 for example means Exendin-4(1-39), a peptide of the sequence H His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
  • [0040]
    Exendin-4 derivatives are for example selected from the following list of compounds:
  • H-(Lys)4-des Pro36, des Pro37 Exendin-4(1-39)-NH2, H-(Lys)5-des Pro36, des Pro37 Exendin-4(1-39)-NH2, des Pro36 [Asp28] Exendin-4(1-39), des Pro36 [IsoAsp28] Exendin-4(1-39), des Pro36 [Met(O)14, Asp28] Exendin-4(1-39), des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39), des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39), des Pro36 [Trp(O2)25, IsoAsp28] Exendin-4(1-39), des Pro36 [Met(O)14 Trp(O2)25, Asp28] Exendin-4(1-39), des Pro36 [Met(O)14 Trp(O2)25, IsoAsp28] Exendin-4(1-39); or des Pro36 [Asp28] Exendin-4(1-39), des Pro36 [IsoAsp28] Exendin-4(1-39), des Pro36 [Met(O)14, Asp28] Exendin-4(1-39), des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39), des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39), des Pro36 [Trp(O2)25, IsoAsp28] Exendin-4(1-39), des Pro36 [Met(O)14 Trp(O2)25, Asp28] Exendin-4(1-39), des Pro36 [Met(O)14 Trp(O2)25, IsoAsp28] Exendin-4(1-39),
  • [0041]
    wherein the group -Lys6-NH2 may be bound to the C-terminus of the Exendin-4 derivative;
    or an Exendin-4 derivative of the sequence
  • H-(Lys)6-des Pro36 [Asp28] Exendin-4(1-39)-Lys6-NH2, des Asp28 Pro36, Pro37, Pro38Exendin-4(1-39)-NH2, H-(Lys)6-des Pro36, Pro38 [Asp28] Exendin-4(1-39)-NH2, H-Asn-(Glu)5des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-NH2, des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39)-Lys6-NH2, H-des Asp28 Pro36, Pro37, Pro38 [Trp(O2)25] Exendin-4(1-39)-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-NH2, H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-NH2, des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36 [Met(O)14, Asp28] Exendin-4(1-39)-Lys6-NH2, des Met(O)14 Asp28 Pro36, Pro37, Pro38 Exendin-4(1-39)-NH2,
  • [0042]
    H-(Lys)6-desPro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,
  • H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2, des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-Asn-(Glu)5 des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-Lys6-des Pro36 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(1-39)-Lys6-NH2, H-des Asp28 Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25] Exendin-4(1-39)-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2, H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(1-39)-NH2, des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2, H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(S1-39)-(Lys)6-NH2, H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2;
  • [0043]
    or a pharmaceutically acceptable salt or solvate of any one of the afore-mentioned Exedin-4 derivative.
  • [0044]
    Hormones are for example hypophysis hormones or hypothalamus hormones or regulatory active peptides and their antagonists as listed in Rote Liste, ed. 2008, Chapter 50, such as Gonadotropine (Follitropin, Lutropin, Choriongonadotropin, Menotropin), Somatropine (Somatropin), Desmopressin, Terlipressin, Gonadorelin, Triptorelin, Leuprorelin, Buserelin, Nafarelin, Goserelin.
  • [0045]
    A polysaccharide is for example a glucosaminoglycane, a hyaluronic acid, a heparin, a low molecular weight heparin or an ultra low molecular weight heparin or a derivative thereof, or a sulphated, e.g. a poly-sulphated form of the above-mentioned polysaccharides, and/or a pharmaceutically acceptable salt thereof. An example of a pharmaceutically acceptable salt of a poly-sulphated low molecular weight heparin is enoxaparin sodium.
  • [0046]
    Pharmaceutically acceptable salts are for example acid addition salts and basic salts. Acid addition salts are e.g. HCl or HBr salts. Basic salts are e.g. salts having a cation selected from alkali or alkaline, e.g. Na+, or K+, or Ca2+, or an ammonium ion N+(R1)(R2)(R3)(R4), wherein R1 to R4 independently of each other mean: hydrogen, an optionally substituted C1-C6-alkyl group, an optionally substituted C2-C6-alkenyl group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6-C10-heteroaryl group. Further examples of pharmaceutically acceptable salts are described in “Remington's Pharmaceutical Sciences” 17. ed. Alfonso R. Gennaro (Ed.), Mark Publishing Company, Easton, Pa., U.S.A., 1985 and in Encyclopedia of Pharmaceutical Technology.
  • [0047]
    Pharmaceutically acceptable solvates are for example hydrates.
  • [0048]
    It will be further apparent to those skilled in the pertinent art that various modifications and variations can be made to the present invention without departing from the spirit and scope of the invention. Further, it is to be noted, that any reference signs used in the appended claims are not to be construed as limiting the scope of the present invention.
  • BRIEF DESCRIPTION OF THE FIGURES
  • [0049]
    In the following, preferred embodiments of the invention are described in greater detail by making reference to the drawings in which:
  • [0050]
    FIG. 1 illustrates a first embodiment of an integrated reminder device in cross-sectional illustration,
  • [0051]
    FIG. 2 shows the reminder device according to FIG. 1 in a top view illustration and
  • [0052]
    FIG. 3 is illustrative of another embodiment of the reminder device with a rotatable ring.
  • DETAILED DESCRIPTION
  • [0053]
    The reminder device as illustrated in FIGS. 1 and 2 is entirely integrated into a housing component 12, 14 of a drug delivery device 10. As particularly illustrated in FIG. 2, the reminder device comprises a display means 18 positioned in a body 12 or main housing component of the drug delivery device. The drug delivery device further comprises a cartridge holder 14 at its distal end section and further has a dose button 16 at its proximal end for selecting and/or setting of a dose and eventually for initiating a dose dispensing procedure.
  • [0054]
    The housing component 12 of the drug delivery device 10 of pen-injector type comprises a rectangular aperture 30 in form of a through opening. Underneath the aperture 30, an adjusting element 22 comprising a sliding element is slidably disposed in axial direction. As illustrated in FIG. 1, the adjusting element 22 comprises a distal surface segment 25 and a proximal surface segment 27. In the centre of the display means 18 or of the adjusting element 22 a radially upwardly, hence radially outwardly protruding gripping member 24 is provided allowing to manually displace the adjusting element 22 in either direction, hence distally, that is to the left in FIG. 1 or proximally, that is to the right in FIG. 2.
  • [0055]
    The adjusting element 22 can be displaced irrespective on the configuration of the drive mechanism of the drug delivery device 10 and/or independent of the filling level of the cartridge, being not further illustrated here. At its upper surface 26 facing towards the aperture 30 in the housing component 14, the adjusting element is provided with visible or haptic information for indicating when the drug delivery device has been used for the last time or when a next usage of the drug delivery is due. Accordingly, since the adjusting element 22 and its information surface 26 comprise two surface segments 25, 27, the illustrated display means 18 is adapted to indicate for instance a particular time or daytime, like morning or evening.
  • [0056]
    Prior to or after usage of the drug delivery device 10 the sliding element 22 can be translationally displaced in distal direction, such that the surface segment 27 becomes visible through the aperture 30 of the housing component 12.
  • [0057]
    Longitudinal displacement of the sliding element 22 can be conducted by the gripping member 24 radially protruding through the aperture 30. Preferably, the free end of the gripping member 24 at least slightly protrudes from the outer surface of the housing component 12, thus facilitating its gripping and a respective axial displacement thereof.
  • [0058]
    As can be further seen from FIG. 1, adjusting element 22 and the base member 12 comprise mutually corresponding latching elements 32, 33, 34, 35. By way of said latching elements 32, 33, 34, 35, the sliding member 22 can be kept and secured in its proximal or distal stop position, respectively. The latching elements 34, 35 of the base member 12 are for instance designed as radially inwardly protruding lugs being at least slightly deformable, thus allowing to displace a corresponding pin 32 of the adjusting element 22 into a position as depicted in FIG. 1. Here, the radially outwardly protruding pin 32 of the adjusting or sliding element 22 is positioned proximal compared to the corresponding radially inwardly protruding lug 34.
  • [0059]
    This way, a form fitting or positive interlock of adjusting element 22 and base member 12 can be attained. Similarly, when moving the adjusting element 22 in distal direction, hence to the left in FIG. 1, latching elements 32, 34 may disengage and upon reaching a distal stop position, oppositely located and mutually corresponding latching elements 33, 35 may engage. By providing a latching or fastening mechanism for the adjusting element 22 by elastically deforming at least one of the interengaging latching elements, a haptic feedback can be provided to the user, that a definite end position of the adjusting element 22 has been reached.
  • [0060]
    The various protruding or latching elements 32, 33, 34, 35 together with corresponding recesses can be integrally formed with the housing components 12, 14 and/or with the adjusting element 22. In particular, when the housing components 12, 14 and/or the adjusting element 22 are designed as injection moulded plastic components, formation of such protruding latching elements 32, 33, 34, 35 or corresponding recesses can be generated almost cost-neutral.
  • [0061]
    Additionally, also the radially protruding gripping member 24 may but against a proximal or distal margin of the rectangular aperture 30 thus preventing any further axial displacement in the respective direction.
  • [0062]
    In a further embodiment according to FIG. 3, the adjusting element 36 comprises a ring rotatably mounted on the outer circumference of a substantially cylindrical base member. In this embodiment, the adjusting element 36 comprises an aperture 38 for discerning or revealing a particular segment of an information surface 40 disposed underneath. With this display means 28 it is intended to rotate the ring-like adjusting element 36 in order to reveal particular time-related information, like certain numbers, abbreviation or even written words.
  • [0063]
    Depending on the frequency of prescribed administering of a dose of the medicament, a plurality of surface segments can be arranged along the circumference of the base member 12. For instance, numbers revealed by the aperture 38 may indicate the time of the day, when a prescribed medication has to be taken. Also, if a medicament has to be taken only once a day, respective abbreviations of the day names will be illustrated in the aperture, indicating on whether the medicament has been taken that particular day.
  • [0064]
    As indicated in FIG. 3, the adjusting ring-like element 36 is directly mounted on a housing component 12 of the drug delivery device 20. However, in particular with retrofitting embodiments it is also conceivable, that the base member is designed as a separate part that can be mounted on the outer circumference of the pen housing 12. This way, also such housing components 12 of drug delivery devices 20 being of non-circular cross-section can be provided with a respective reminder device, wherein the base member provides a respective compensation means for mounting a rotatable ring 36 onto a non-circular-shape pen housing 12.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US5279585 *4 Feb 199218 Jan 1994Becton, Dickinson And CompanyMedication delivery pen having improved dose delivery features
US5279586 *4 Feb 199218 Jan 1994Becton, Dickinson And CompanyReusable medication delivery pen
US5482163 *27 Dec 19949 Jan 1996Hoffman; Kenneth L.Last event indicator
US5693027 *26 Sep 19942 Dec 1997Novo Nordisk A/SAdaptor top
US5728074 *5 Dec 199417 Mar 1998Visionary Medical Products, Inc.Pen-type injector with a microprocessor and blood characteristic monitor
US5823346 *6 Aug 199720 Oct 1998Weiner; Steven L.Medicine bottle reminder attachment
US8001963 *3 Sep 200423 Aug 2011Kurve Technology, Inc.Integrated nebulizer and particle dispersion chamber for nasal delivery of medicament to deep nasal cavity and paranasal sinuses
US8202255 *26 Mar 200719 Jun 2012Terumo Corp.Dose display mechanism for a drug delivery device
US8298194 *23 Feb 200730 Oct 2012Novo Nordisk A/SInjection device and a method of changing a cartridge in the device
US8348904 *14 Mar 20088 Jan 2013Novo Nordisk A/SMedical delivery system having container recognition and container for use with the medical delivery system
US20020022821 *9 Aug 200121 Feb 2002Michael EilersenElectronic marking of a medication cartridge
US20020165500 *5 Jun 20017 Nov 2002Herbert BechtoldInjection device
US20030120222 *29 Jan 200226 Jun 2003Vaillancourt Vincent L.Safety needle
US20050183982 *17 Feb 200525 Aug 2005Harry GiewercerExtended use reminder device
US20080051692 *30 Nov 200628 Feb 2008Transport Pharmaceuticals, Inc.Applicator cartridge for an electrokinetic delivery system for self administration of medicaments
US20090062728 *29 Aug 20085 Mar 2009Sang Hoon WooControl of Body Fluid Condition Using Diuretics, Based on Weight Measurement
US20090062730 *29 Aug 20085 Mar 2009San Hoon WooControl of body fluid condition using diuretics, based on biological parameters
US20120071834 *31 Mar 201022 Mar 2012Sanofi-Aventis Deutschland GmbhMethod of manufacturing a drug delivery device body
US20120089098 *21 Dec 200912 Apr 2012Sanofi-Avetnis Deutschland GmbhDrug Delivery Device
US20120101445 *15 Jan 201026 Apr 2012Sanofi-Aventis Deutschland GmbhMedicament Identification System for Multi-Dose Injection Devices
US20120232517 *17 May 201213 Sep 2012Terumo CorporationDose Display Mechanism for a Drug Delivery Device
US20120310172 *29 Sep 20106 Dec 2012Sanofi-Aventis Deutschland GmbhDrug Delivery Device
US20120330228 *29 Nov 201027 Dec 2012Sanofi-Aventis Deutschland GmbhDevice and method for delivery of two or more drug agents
US20130072897 *21 Jan 201121 Mar 2013Sanofi-Aventis Deutschland GmbhMethod and system for determining information related to a drug reservoir
US20130079708 *25 Mar 201128 Mar 2013Sanofi-Aventis Deutschland GmbhElectro-mechanical drug delivery device
US20130096511 *3 May 201118 Apr 2013Sanofi-Aventis Deutschland GmbhTactile identification of drug filled cartridge
US20130131601 *7 Apr 201123 May 2013Sanofi-Aventis Deutschland GmbhMethod and system for differentiating drug delivery devices
US20130226095 *26 Aug 201029 Aug 2013Sanofi-Aventis Deutschland GmbhReminder Device for a Pen-Shaped Medical Delivery Device
WO2008042701A2 *27 Sep 200710 Apr 2008Arrow International, Inc.Syringe with selectable indicia of contents
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US88999878 Aug 20132 Dec 2014Kaleo, Inc.Simulated medicament delivery device having an electronic circuit system
US893225221 Jun 201313 Jan 2015Kaleo, Inc.Medical injector simulation device
US893994324 Oct 201327 Jan 2015Kaleo, Inc.Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US894506317 Jan 20143 Feb 2015Antares Pharma, Inc.Hazardous agent injection system
US902298027 Feb 20075 May 2015Kaleo, Inc.Medical injector simulation device
US908484925 Jan 201221 Jul 2015Kaleo, Inc.Medicament delivery devices for administration of a medicament within a prefilled syringe
US91446482 May 200729 Sep 2015Antares Pharma, Inc.Injector with adjustable dosing
US917399925 Jan 20123 Nov 2015Kaleo, Inc.Devices and methods for delivering medicaments from a multi-chamber container
US91802595 Feb 201410 Nov 2015Antares Pharma, Inc.Prefilled syringe jet injector
US922066015 Jul 201129 Dec 2015Antares Pharma, Inc.Liquid-transfer adapter beveled spike
US923810817 Jul 201219 Jan 2016Kaleo, Inc.Medicament delivery device having an electronic circuit system
US925953927 Aug 201416 Feb 2016Kaleo, Inc.Devices, systems and methods for medicament delivery
US927818220 Mar 20158 Mar 2016Kaleo, Inc.Devices, systems and methods for medicament delivery
US933330922 Jun 201410 May 2016Antares Pharma, Inc.Intradermal injector
US93646107 May 201314 Jun 2016Antares Pharma, Inc.Injection device with cammed ram assembly
US93646117 May 201314 Jun 2016Antares Pharma, Inc.Needle assisted jet injection device having reduced trigger force
US93933673 Apr 201519 Jul 2016Antares Pharma, Inc.Prefilled syringes and kits thereof
US9402959 *21 Sep 20102 Aug 2016Sanofi-Aventis Deutschland GmbhAssembly for a drug delivery device and drug delivery device
US944619528 Jun 201320 Sep 2016Antares Pharma, Inc.Injection device with cammed ram assembly
US9463284 *1 Dec 201011 Oct 2016Sanofi-Aventis Deutschland GmbhDose display mechanism for drug delivery device with first and second windows and scales
US947486923 Apr 201525 Oct 2016Kaleo, Inc.Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US94865835 Mar 20138 Nov 2016Antares Pharma, Inc.Prefilled syringe with breakaway force feature
US951730718 Jul 201413 Dec 2016Kaleo, Inc.Devices and methods for delivering opioid antagonists including formulations for naloxone
US952223514 Mar 201320 Dec 2016Kaleo, Inc.Devices and methods for delivering medicaments from a multi-chamber container
US954282626 Jun 201510 Jan 2017Kaleo, Inc.Devices, systems and methods for locating and interacting with medicament delivery systems
US955519116 Feb 201631 Jan 2017Kaleo, Inc.Apparatus and methods for self-administration of vaccines and other medicaments
US956133312 Dec 20147 Feb 2017Antares Pharma, Inc.Multiple dosage injector
US962995913 Jul 201625 Apr 2017Antares Pharma, Inc.Prefilled syringe jet injector
US9669202 *2 Jul 20106 Jun 2017Sanofi-Aventis Deutschland GmbhDrug delivery device and set of a drug delivery device and a plurality of mountable elements
US970735411 Mar 201418 Jul 2017Antares Pharma, Inc.Multiple dosage injector with rack and pinion dosage system
US97244713 Apr 20148 Aug 2017Kaleo, Inc.Devices, systems, and methods for medicament delivery
US97376705 Apr 201622 Aug 2017Antares Pharma, Inc.Intradermal injector
US974430211 Feb 201429 Aug 2017Antares Pharma, Inc.Needle assisted jet injection device having reduced trigger force
US975088122 Aug 20165 Sep 2017Antares Pharma, Inc.Hazardous agent injection system
US98056209 Jan 201531 Oct 2017Kaleo, Inc.Medical injector simulation device
US98085824 Apr 20147 Nov 2017Antares Pharma, Inc.Two-stage reconstituting injector
US20120238960 *2 Jul 201020 Sep 2012Sanofi-Aventis Deutschland GmbhDrug delivery device and set of a drug delivery device and a plurality of mountable elements
US20120259285 *21 Sep 201011 Oct 2012Sanofi-Aventis Deutschland GmbhAssembly for a drug delivery device and drug delivery device
US20130016105 *1 Dec 201017 Jan 2013Sanofi-Aventis Deutschland GmbhDose display mechanism for a drug delivery device
Classifications
U.S. Classification604/189
International ClassificationA61M5/31
Cooperative ClassificationA61M5/31533, A61J7/04, A61M2205/6063
European ClassificationA61J7/04
Legal Events
DateCodeEventDescription
22 Jun 2012ASAssignment
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DASBACH, UWE;LANIN, IRINA;RABE, PEGGY;REEL/FRAME:028425/0923
Effective date: 20120606